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AtherosclerosisAbstract Background: It is a common practice to heat cooking oil and reuse it in order to cut
expenses. The use of repeatedly heated cooking oil predisposes to various cardiovascular diseases.
Virgin coconut oil (VCO) is reported to possess antioxidant action.
Aim: The study aimed to determine the effect of heating of VCO on the blood pressure (BP) and
inﬂammatory bio-markers.
Methods: Thirty male Sprague-Dawley rats were divided into ﬁve groups and were fed with the fol-
lowing diet for 24 weeks: normal rat chow (control); chow + fresh VCO (FVCO); chow + VCO
heated once (1HVCO); chow + VCO heated ﬁve times (5HVCO) and chow + VCO heated ten
times (10HVCO). BP was measured at baseline and four weekly for 24 weeks. Blood was collected
at baseline and at the end of study to measure plasma TXB2, PGI2, VCAM-1, ICAM-1 and LDH
enzyme activity.
Results: BP increased signiﬁcantly in the 5HVCO and 10HVCO groups compared to the control
and FVCO groups. The 5HVCO and 10HVCO diet caused a signiﬁcant increase in the plasma
54 M.A. Hamsi et al.TXB2 and a signiﬁcant decrease in the plasma PGI2 level. The plasma levels of VCAM-1, ICAM-1
and CRP were signiﬁcantly increased in the 10HVCO group.
Conclusion: Repeatedly heated VCO caused an elevation in the BP. The BP elevation was associ-
ated with a signiﬁcant increase in the inﬂammatory bio-markers (VCAM-1, ICAM-1 and CRP),
TXB2 and a signiﬁcant reduction in the plasma PGI2 level.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.1. Introduction
Cooking oils possess different fatty acid composition. Soy oil
contains 60% polyunsaturated fatty acids (PUFA), 24%
monounsaturated fatty acids (MUFA) and 16% saturated
fatty acids (SFA). In contrast, palm oil contains 50% MUFA,
50% SFA. Soy oil is rich in tocopherol, whilst palm oil is rich
in tocotrienols. Both possess antioxidant properties that act as
free radical scavengers.1 Tocotrienols have greater antioxidant
properties compared to the tocopherols.2
Coconut (Cocos nucifera) is a fruit which is abundant in the
tropical and subtropical countries such as Philippines, Malay-
sia, Indonesia and India. Over the past ten decades, coconut
products have been used either as a food or medication.3 There
is extensive research on coconut oil in order to explore its po-
tential uses. Coconut oil is used as edible oil for domestic con-
sumption. Several methods are employed to extract the
coconut oil, which involve either dry or wet processing. In
dry processing, the coconut oil is extracted from the copra
i.e. the dried kernel. The oil then undergoes the process of
reﬁning, bleaching and deodorizing (RBD) which involves
chemicals and heating at a high temperature.
Virgin coconut oil (VCO) may be deﬁned as the oil which is
obtained from the fresh and mature kernel of the coconut by
mechanical or natural means with or without the use of heat
and without subjecting it to any chemical RBD process.4
Hence, the process to extract VCO is also known as the wet
extraction method. The fatty acid contents of the VCO, are
mainly medium chain saturated fatty acid (MCFA) (50%);
lauric acid, short chain saturated fatty acids (SCFA) such as
capric, caproic and caprylic acid and unsaturated fatty acids
(8%).5 The advantage of the wet extraction method is due to
the fact that the oil retains more biologically active compo-
nents such as tocotrienols, polyphenols and tocopherols, that
possess the antioxidant properties.4,6 Instead of being con-
sumed as cooking oil, VCO is considered as a functional food
supplement. Other than the antioxidant properties, VCO has
been reported to have antibacterial, antiviral, antinociceptive,
and anti-inﬂammatory and lipid lowering effect.7–10
Soy oil and palmoil are commonly used for deep frying.How-
ever, it has been a common practice to heat the oil repeatedly, in
order to save the cost. The oil is discarded only if the physical
appearance of the oil deteriorates.11 It has been documented that
consumption of repeatedly heated palm oil causes an increase in
the blood pressure (BP) and impaired endothelium-dependent
vascular relaxation.12 Previous study has shown that consump-
tion of repeatedly heated soy oil was predisposed to atherosclero-
sis.1 Inﬂammation and oxidative stress are attributed to the
pathogenesis of hypertension and atherosclerosis.12 Hyperten-
sion is related to the disturbanceof homoeostasis of thromboxane
A2 (TXA2) and prostacyclin (PGI2).
13 The two oxygenatedmetabolites of arachidonic acid have potent and contrasting ef-
fects on vascular tone and platelet function.13 Inﬂammation has
been implicated in pathogenesis of atherosclerosis and has been
shown to be associated with an increase in inﬂammatory bio-
markers such as an increase in the level of C-reactive protein
(CRP), vascular cell adhesion molecule (VCAM-1) and intercel-
lular adhesion molecule (ICAM-1).14 Elevation in the lactate
dehydrogenase (LDH) enzyme activity also indicates the distur-
bance in the normal functioning of the heart.15
VCO is gaining popularity as cooking oil in the society. The
present study aimed to determine the effect of heated VCO on
blood pressure and inﬂammatory biomarkers. To the best of
our knowledge, this may be the ﬁrst study of its kind. We pos-
tulated that VCO being rich in heat stable antioxidant may
have no detrimental effect on BP and related biomarkers.
Hence, it may be consumed as frying edible oil in future.
2. Methods
2.1. Animals and study design
A total of thirty adult male Sprague-Dawley rats aged 3 months
(weighing 200–280 gm)were obtained from anAnimalHouse of
Universiti Kebangsaan Malaysia. Ethical approval was ob-
tained from University Animal Ethics Committee prior to the
study (Permit No. PP/ANAT/2011/SRIJIT/19-MAY/370-
MAY-2011-AUGUST-2012). The animals were managed and
procedures were performed as per the recommended guidelines.
The rats were kept in plastic cages and maintained at room tem-
perature of 25 ± 2 Cwith a 12 h light–dark cycle. The rats were
allowed to acclimatize for 1 weekprior to studywith the test diet.
All rats had free access to food and water ad libitum during the
study period.16 The rats were randomly divided into ﬁve groups
comprising six animals per group. Following 1 week of acclima-
tization, the following diets were fed to each group of rats: group
I (control) was fed only with commercial rat chow (basal diet);
group IIwas fedwith basal diet fortiﬁedwith 15%weight/weight
(w/w) of fresh VCO (FVCO); group III was fed with basal diet
fortiﬁed with VCO heated once (1HVCO); group IV was fed
with basal diet fortiﬁed with VCO heated ﬁve times (5HVCO)
and group V was fed with basal diet fortiﬁed with VCO heated
ten times (10HVCO) for 24 weeks. BP was measured at baseline
and at intervals of 4 weeks for 24 weeks using a non-invasive
method. Blood was collected through the orbital sinus prior to
the treatment, and at the end of study. The blood was then cen-
trifuged to obtain plasma for the biochemical analysis.
2.2. Preparation of oil diet
VCO used for this study was purchased from local manufac-
turer Organic Gain Sdn Bhd (Bangi, Selangor, Malaysia). It
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ten times as per earlier protocol described by Owu et al.
with few modiﬁcations.17 Brieﬂy, 2.5 L of oil was heated
to 180 C in a stainless steel wok and used to deep-fry
1 kg sliced sweet potatoes. The heating process lasted for
15 min. The hot oil was then left to cool at room tempera-
ture for 5 h. This procedure resulted in the once heated
VCO group (1HVCO). The pre-cooled hot oil was used to
deep-fry another new batch of sweet potatoes. The frying
process was carried out without adding any fresh oil to com-
pensate for oil losses. In order to obtain VCO heated ﬁve
times (5HVCO) and VCO heated ten times (10HVCO), the
same heating procedure was repeated four and nine times,
respectively. The experimental diets were prepared twice in
a week. Standard rat chow (Gold Coin, Port Klang, Selan-
gor, Malaysia) was ground and mixed with some water and
fresh or the heated VCO prepared. The weight ratio of rat
chow to the oil was 100:15. The mixture was then dried at
70 C overnight in an oven.
2.3. Measurement of blood pressure
Systolic blood pressure (SBP) of pre-warmed conscious rats
was measured by the non-invasive tail cuff method
using PowerLab data acquisition systems (ADInstruments,
Castle Hill, NSW, Australia). Minimum ﬁve measurements
were recorded and the mean SBP was used in further
analysis.16
2.4. Measurement of plasma TXB2 and PGI2
The plasma TXB2 and PGI2 were measured using commer-
cially available ELISA kit (Cusabio, USA) according to the
manufacturer’s instruction.13,18 The intensity of coloured
product was measured at absorbance 450 nm in a micro
plate reader (VERSA, USA). The result was calibrated by
the software calculation that was provided with the micro
plate reader and compared to the calibration standard
curve.
2.5. Measurement of plasma VCAM-1 and ICAM-1
The quantiﬁcation of soluble VCAM-1 and soluble ICAM-1
was determined using commercially available ELISA kit from
USCN Life Science Inc. (Wuhan, China) and Abnova (Taipei,
Taiwan), respectively following manufacturer’s instruction.14
Absorbance at 450 nm was determined using VERSA micro
plate reader (USA). Values of samples were calculated by the
software provided with the micro plate reader and compared
to the standard curve generated.
2.6. Measurement of plasma CRP
The plasma of CRP was determined using commercially avail-
able ELISA kit (Abnova, Taipei, Taiwan) in accordance with
the manufacturer’s instruction.14 The intensity of coloured
product was measured using VERSA micro plate reader
(USA) at 450 nm absorbance. Values of samples were calcu-
lated by the software provided with the micro plate reader
and compared with the standard curve generated.2.7. Measurement of plasma LDH
The activity of LDH was determined using commercially avail-
able kit (BioVision, USA).19 The standards and samples were
prepared following manufacturer’s instruction. The intensity
of coloured product (NADH) was measured using VERSA
micro plate reader (USA) at 450 nm. OD 450 nm was measured
to read A1 and incubated at 37 C for 30 min. Following the
incubation OD 450 nm was measured again to read A2. The
standard curve was generated using the A2 reading after sub-
tracting the blank reading. Values of NADH at A1 and A2
were calculated from the standard curve, and the LDH activity
calculation was based on the manufacturer’s instruction:
LDH Activity ¼ BðT2 T1Þ  V Sample dilution
¼ nmol=min=mlmU=ml
B was the NADH amount that was generated between T1 and
T2 (Value A2 – Value A1) in nmol.
T1 was the time for ﬁrst reading (A1) in min.
T2 was the time for second reading (A2) in min.
V was the pre-treated sample volume added into the reac-
tion well (in ml).
Unit deﬁnition: One unit LDH was the amount of enzyme
that catalysed the conversion of lactate to pyruvate to generate
1.0 lmol to NADH per minute at 37 C.
2.8. Measurement of peroxide value (PV)
The PV of VCO was determined using the standard titration
method (Ofﬁcial method Cd 8-53) as described by the Ameri-
can Oil Chemists’ Society (AOCS). The peroxide value was ex-
pressed as mille-equivalents of active oxygen per kilogram of
oil sample (mEq O2/kg).
2.9. Statistical analysis
The data was presented as the mean ± standard error of mean
(SEM). The normality of all the data was ﬁrst determined by
Kolmogorov–Smirnov test. Statistical differences were
determined using paired student’s t-test, or one-way analysis
of variance (ANOVA) followed by Tukey HSD post hoc test.
Data that were not normally distributed were analysed using
non-parametric tests, i.e. Wilcoxon-Signed-Rank test or
Kruskal–Wallis test. A value of p< 0.05 was considered to
be signiﬁcant. All analyses were performed using SPSS
software version 20.0 (SPSS Inc., Chicago, USA).
3. Results
3.1. Food intake and body weight
The oil fed groups (FVCO, 1HVCO, 5HVCO and 10HVCO)
showed a signiﬁcant (p< 0.05) lower food intake compared to
the control group (Fig. 1). Nevertheless, all groups showed a sig-
niﬁcant increase in the body weight at the end of study period
compared to respective baseline value (p< 0.05). Body weight
in 1HVCO, 5HVCOand 10HVCOgroups was signiﬁcantly high-
er compared to control and FVCO groups (p< 0.05) (Fig. 1).
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At the end of 24-week feeding period, there was a signiﬁcant
increase in the BP (p< 0.05) in 5HVCO and 10HVCO groups
compared to the control and FVCO groups. There were no sig-
niﬁcant changes in BP in the control, FVCO and 1HVCO
(Fig. 2).
3.3. Plasma TXB2
There was a signiﬁcant increase (p< 0.05) in the TXB2 level in
the 5HVCO and 10HVCO groups compared to the control.
The increase in the TXB2 level in 10HVCO was signiﬁcantly
higher (p< 0.05) compared to the other groups. However,
there were no signiﬁcant changes in the TXB2 level in the con-
trol, FVCO and 1HVCO groups (Fig. 3).Figure 1 Food intake and body weight gain of rats fed with respec
(FVCO), VCO heated once (1HVCO), VCO heated ﬁve times (5HVC
Data are shown as means ± SEM (n= 6). ‘a’ is signiﬁcant difference
Figure 2 Effects of fresh and heated VCO on blood pressure in adul
normal rat chow (control), FVCO, 1HVCO, 5HVCO or 10HVCO after
is signiﬁcant difference between pre- and post-treatment values for th
control and FVCO groups (p< 0.05).3.4. Plasma PGI2
There was a signiﬁcant decrease in PGI2 (p< 0.05) in the
5HVCO and 10HVCO groups compared to respective baseline
value. The level of PGI2 in the 10HVCO group was signiﬁ-
cantly lower (p< 0.05) compared to the rest of the groups.
However, there was no signiﬁcant difference in PGI2 in the
control, FVCO and 1HVCO groups compared to the respec-
tive baseline (Fig. 4).
3.5. Plasma VCAM-1
There was no signiﬁcant difference in VCAM-1 level between
the pre-treatment and post-treatment in the control, 1HVCO
and 5HVCO groups. There was a signiﬁcant (p< 0.05) de-
crease in the level of VCAM-1 in the FVCO compared totive diets after 24 weeks. Normal rat chow (control), fresh VCO
O) or VCO heated ten times (10HVCO) after 24 weeks of feeding.
compared to control groups (p< 0.05).
t male rats. Shown are the blood pressure changes in rats fed with
24 weeks of feeding. Data are shown as means ± SEM (n= 6). ‘a’
e same group (p< 0.05). ‘b’ is signiﬁcant difference compared to
Figure 3 Determination level of TXB2 in the pre-treatment and post-treatment in the different groups. ‘a’ is signiﬁcant difference
between pre- and post-treatment values for the same group (p< 0.05). ‘b’ is signiﬁcant difference compared to other groups (p< 0.05).
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VCAM-1 level in the 10HVCO group (p< 0.05) compared to
the other groups (Fig. 5).
3.6. Plasma ICAM-1
There was no signiﬁcant difference in ICAM-1 level before and
after the study in all groups except for the 10HVCO group.
However, there was a signiﬁcant increase in ICAM-1
(p< 0.05) in the 10HVCO group compared to the rest of
the groups (Fig. 6).3.7. Plasma CRP
There was a signiﬁcant increase in CRP level (p< 0.05) in the
10HVCO group compared to baseline and all other groups
(Fig. 7).Figure 4 Determination level of PGl2 in the pre-treatment and post-tr
pre- and post-treatment values for the same group (p< 0.05). ‘b’ i
(p< 0.05). ‘c’ is signiﬁcant difference compared to other groups (p<3.8. Plasma LDH activities
There was no signiﬁcant change in the LDH activity in the
control and FVCO groups. However, there was a signiﬁcant
increase in LDH activity in the 1HVCO, 5HVCO and
10HVCO compared to baseline value (Fig. 8).
3.9. Correlation between the inﬂammatory markers and blood
pressure
There was a strong signiﬁcant positive relationship between
VCAM-1, ICAM-1, CRP and TXB2 with BP. This suggests
that elevation in the blood pressure in this study may be a con-
sequence of vascular inﬂammation as reﬂected by an increase
in VCAM-1, ICAM-1 and CRP in the circulation. The vascu-
lar inﬂammation subsequently impaired production of TXB2
by vascular endothelium leading to an increase in the BP. Ineatment in the different groups. ‘a’ is signiﬁcant difference between
s signiﬁcant difference compared to FVCO and 1HVCO group
0.05).
Figure 5 Determination level of VCAM-1 in the pre-treatment and post-treatment in the different groups. ‘a’ is signiﬁcant difference
between pre- and post-treatment values for the same group (p< 0.05). ‘b’ is signiﬁcant difference compared to other groups (p< 0.05).
Figure 6 Determination level of ICAM-1 in the pre-treatment and post-treatment in the different groups. ‘a’ is signiﬁcant difference
between pre- and post-treatment values for the same group (p< 0.05). ‘b’ is signiﬁcant difference compared to other groups (p< 0.05).
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BP. This suggests that the reduction of PGI2 in the circulation
may contribute to the elevation of BP (Figs. 9–13).
3.10. Peroxide value
VCO has lower PV value. However, PV value increases signif-
icantly (p< 0.05) once the VCO was heated. The PV of
1HVCO, 5HVCO and 10HVCO samples was signiﬁcantly
higher when compared to the PV of FVCO (Fig. 14).
4. Discussion
In the present study, there was a signiﬁcant increase in body
weight of all groups compared to their respective baseline val-
ues. In spite of lower food intake the body weight increment
was more in the 1HVCO, 5HVCO and 10HVCO groups com-
pared to the control and FVCO groups. The weight gain for
the FVCO fed group was lower compared to the control
group. This ﬁnding suggests that consumption of FVCO didnot lead to abnormal weight gain despite high saturated fatty
acid content. The saturated fatty acids in VCO consist of med-
ium chain fatty acids (MCFA) that are made up of 8–10 car-
bons. MCFA has different characteristics compared to
long-chain fatty acids (LCFA) in terms of digestion, absorp-
tion, biodegradation and body-fat accumulation.20
MCFA is easily digested and absorbed compared to the
LCFA. MCFA is directly absorbed into circulation and deliv-
ered to the liver, where it was metabolized faster into energy.
Thus, it prevents body-fat accumulation.20 The result of the
present study was similar to earlier results. In contrast, we ob-
served that the rats fed with 1HVCO, 5HVCO and 10HVCO
had signiﬁcantly higher weight gain compared to the control
and FVCO groups. This ﬁnding suggests that consumption
of heated VCO may lead to overweight, which is one of the risk
factors for cardiovascular disease. This ﬁnding was in line with
earlier studies which showed that animals that consumed
repeatedly heated palm oil and soy oil exhibited greater body
weight gain compared to the control group.12,21
Few studies observed that polyunsaturated fatty acids (PU-
FAs) were relatively unstable compared to the saturated fatty
Figure 7 Determination level of CRP in the pre-treatment and post-treatment in the different groups. ‘a’ is signiﬁcant difference between
pre- and post-treatment values for the same group (p< 0.05). ‘b’ is signiﬁcant difference compared to other groups (p< 0.05).
Figure 8 Determination level of LDH activity in the pre-treatment and post-treatment in the different groups. ‘a’ is signiﬁcant difference
between pre- and post-treatment values for the same group (p< 0.05). ‘b’ is signiﬁcant difference compared to other groups (p< 0.05).
VCO and inﬂammatory biomarkers 59acids (SFAs).22,23 PUFA was more susceptible to oxidation
that leads to lipid peroxidation and oxidative stress. Previous
studies reported that consumption of repeatedly heated cook-
ing oil increased BP.12,16,24 The BP raising effect of heated oils
was attributable to oxidative stress.12,16,24 VCO being high in
SFA would be more stable for usage as frying oil. Previous
study reported that VCO has relatively high oxidative stability
similar to the extra-virgin olive oil (EVOO) and palm
olein.22,23 Unexpectedly we observed that repeatedly heated
VCO causes BP elevation in spite of low oxidation index com-
pared to the palm oil and olive oil.22,23
However, we noted that FVCO and 1HVCO did not cause
signiﬁcant increase in BP. In the present study, the increase inBP in 5HVCO and 10HVCO groups was associated with a sig-
niﬁcant increase in the plasma, ICAM, VCAM, CRP and
TXB2 levels and a signiﬁcant decrease in PGI2. The strong po-
sitive correlation between BP changes with ICAM, VCAM,
CRP and TXB2 suggesting that vascular inﬂammation may
play an important role in BP raising effect of VCO. TXA2 is
a potent pro-aggregator and vasoconstrictor prostanoid. It is
produced and released by the platelets during aggregation
and is rapidly metabolized to its stable breakdown product,
thromboxane B2 (TXB2)
25 whilst PGI2 produce vasodilation.
The homoeostasis of TXA2 and PGI2 is crucial for the BP reg-
ulation. Our ﬁnding was similar to previous studies which re-
ported that the release of TXB2 and prostacyclin were
Figure 9 The correlation between changes in TXB2 and blood
pressure r= 0.722, p< 0.05.
Figure 10 The correlation between changes in VCAM-1 and
blood pressure r= 0.592, p< 0.05.
Figure 11 The correlation between changes in ICAM-1 and
blood pressure r= 0.722, p< 0.05.
Figure 12 The correlation between changes in CRP and blood
pressure r= 0.615, p< 0.05.
60 M.A. Hamsi et al.increases and decreases, respectively in the hypertensive
rats.26,27 Ng et al. reported that the increase in BP with heated
oil was associated with an increase in the TXA2/PGI2 ratio.
28
Again, this abnormality may be due to the abnormal platelet
functions which is source of TXA2 and PGI2.
29
We postulated that repeatedly heated VCO produced oxi-
dative stress that causes endothelial vascular inﬂammation
which may interfere with the release of vasoactive substance
such as thromboxane (TXB2) and prostacyclin (PGI2). The
thermal oxidation occurring during repeatedly heating of the
oil generates reactive oxygen species (ROS) which causedamage to the cells. This ROS is considered to be a major
cause of endothelial dysfunction and vascular inﬂammation.30
VCAM-1 and ICAM-1 are adhesion molecules involved in
the rolling, adhesion and extravasation of leukocytes, mainly
mononuclear cells to the inﬂammation site.14 The upregulation
of these adhesion molecules is accompanied by the release of
its soluble fraction into the bloodstream. The increased expres-
sion of VCAM-1 and ICAM-1 and CRP is a common process
in inﬂammation. Few studies reported a strong positive corre-
lation between the VCAM-1 and ICAM expression and BP in
repeatedly heated cooking oil.31,32 These three inﬂammatory
Figure 13 The correlation between changes in PGl2 and blood pressure r= 0.727, p< 0.05.
Figure 14 Peroxide value for FVCO, 1HVCO, 5HVCO and 10HVCO. ‘a’ signiﬁcant difference compared to FVCO (p< 0.05); ‘b’
signiﬁcant difference compared to 1HVCO (p< 0.05); ‘c’ signiﬁcant difference compared to 5HVCO (p< 0.05).
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cular disease such as hypertension and atherosclerosis.14,33,34
In the present study, the LDH activity was increased in
the 1HVCO, 5HVCO and 10HVCO groups, which may
suggest that heated VCO may cause tissue damage. LDH
activity has been reported to be abnormal in a large number
of disorders.35 Although, the increase in LDH activity isnon-speciﬁc, the tissue damages may be due to inﬂammation
caused by the ROS that was generated by the thermal oxida-
tion of repeatedly heating the oil, and this caused the endo-
thelial cell injury.35 Considering the ﬁndings from previous
studies, it is clear that consumption of repeatedly heated
cooking oil is one of the risk factors for the development
of cardiovascular diseases.1,12,16,31 Our ﬁndings on repeatedly
62 M.A. Hamsi et al.heated VCO were in accordance with earlier ﬁndings, which
reported that heated oil increases blood pressure. However,
in the present study the BP raising effect of heated VCO
was only noted in 5HVCO and 10HVCO groups. Our ﬁnding
was in contrast to previous studies which reported that
heated once soy, two times, ﬁve times and ten times palm
oil increase blood pressure. These ﬁndings may suggest that
the heated VCO appears to be more stable compared to
heated palm and soy oil as only 5HVCO and 10HVCO in-
creased the BP. The scientiﬁc reason behind this fact is not
well understood and needs further exploration. There is a
possibility that the high concentration of heat stable antiox-
idant such as polyphenols in VCO may protect the thermal
oxidation of the oil and prevent from free radical induced in-
jury such as hypertension. Therefore, it is recommended not
to heat the VCO repeatedly, as it may destroy antioxidants as
reﬂected by an increase in PV of heated VCO.
In this study, we used sweet potato as a common vehicle for
preparing repeatedly heated frying oil. This was in accordance
with a previous study which used sweet potato for frying.36
Reason for using sweet potato in this study is because we do
not want the fried food such as ﬁsh or meat to interfere with
the oil’s peroxide value.37
There were few limitations which were encountered. Admit-
tedly, we did not make an adjustment for the food intake for
the difference in body weight gain among the groups. Sec-
ondly, the best method to measure VCAM and ICAM was
by immunohistochemistry using blood vessel rather than the
soluble form. Thirdly the increase in BP should have been ad-
justed for body weight gain, and other potential factors.
Further studies are needed to elucidate the possible mecha-
nism of the BP raising effect of VCO. Studies reported that
consumption of fresh VCO has a beneﬁcial role in improving
antioxidant status and preventing lipid and protein abnormal-
ity.38 The present ﬁndings also showed that consumption of
fresh VCO did not produce detrimental effect on blood pres-
sure, inﬂammatory biomarkers and helped to reduce body
weight. Hence, it may be suggested that consumption of fresh
VCO has a potential role in preventing cardiovascular diseases.
It is always beneﬁcial to follow ofﬁcial methods and recom-
mended practices for heating oils.39
5. Conclusion
In conclusion, fresh VCO has no detrimental effect on blood
pressure, inﬂammatory biomarkers and helps to reduce body
weight in test animals. Repeatedly heated VCO increases BP
and inﬂammatory biomarkers just like heated palm and soy
oil. Therefore, VCO is more suitable to be consumed in a fresh
form for health beneﬁt.
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